A detailed history of Portland Investment Counsel Inc. transactions in Olema Pharmaceuticals, Inc. stock. As of the latest transaction made, Portland Investment Counsel Inc. holds 12,000 shares of OLMA stock, worth $75,840. This represents 0.06% of its overall portfolio holdings.

Number of Shares
12,000
Holding current value
$75,840
% of portfolio
0.06%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$10.41 - $16.46 $124,920 - $197,520
12,000 New
12,000 $143,000

Others Institutions Holding OLMA

About Olema Pharmaceuticals, Inc.


  • Ticker OLMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,419,600
  • Market Cap $255M
  • Description
  • Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...
More about OLMA
Track This Portfolio

Track Portland Investment Counsel Inc. Portfolio

Follow Portland Investment Counsel Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Portland Investment Counsel Inc., based on Form 13F filings with the SEC.

News

Stay updated on Portland Investment Counsel Inc. with notifications on news.